Beeckman D, Verhaeghe S, Defloor T, Schoonhoven L, Vanderwee K, et al.
Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy an.... Date of publication 2011 Nov 1;volume 38(6):627-34.
1. J Wound Ostomy Continence Nurs. 2011 Nov-Dec;38(6):627-34. doi:
10.1097/WON.0b013e31822efe52.
A 3-in-1 perineal care washcloth impregnated with dimethicone 3% versus water
and pH neutral soap to prevent and treat incontinence-associated dermatitis: a
randomized, controlled clinical trial.
Beeckman D(1), Verhaeghe S, Defloor T, Schoonhoven L, Vanderwee K.
Author information:
(1)Florence Nightingale School of Nursing & Midwifery, King's College London,
United Kingdom. dimitri.beeckman@kcl.ac.uk
PURPOSE: We compared the effectiveness of a 3-in-1 perineal care washcloth
versus standard of care (water and pH neutral soap) to prevent and treat
incontinence-associated dermatitis (IAD). The product under study was a soft,
premoistened washcloth, including a 3% dimethicone formula, with cleansing,
moisturizing, and barrier protection properties.
DESIGN: Randomized, controlled clinical trial.
SUBJECTS AND SETTING: The study sample comprised a random sample of 11 nursing
home wards (6 experimental and 5 control) in a convenience sample of 4 nursing
homes in Belgium. The sample included nursing home residents at risk for and/or
affected by IAD defined as incontinent of urine, feces, urine/feces, and/or
having erythema of the perineal skin (not caused by pressure/shear), and/or
having an edematous skin in the genital area.
METHODS: Participants in the experimental group were treated according to a
standardized protocol, including the use of a 3-in-1 perineal care washcloth
impregnated with a 3% dimethicone skin protectant. Participants in the control
group received perineal skin care with water and pH neutral soap, the standard
of care in Belgian nursing homes. The study period was 120 days. Data were
collected between February and May 2010. Incontinence-associated dermatitis
prevalence and severity were assessed using the IAD Skin Condition Assessment
Tool. The surface (cm), redness, and depth of the perineal lesion were assessed
daily by the nurses. This tool generates a cumulative severity score (maximum
score = 10) based on area of skin affected, degree of redness, and depth of
erosion.
RESULTS: Four hundred sixty-four nursing home residents were assessed and 32.9%
(n = 141) met the criteria for inclusion, including 73 subjects in the
experimental group and 68 in the control group. Baseline IAD prevalence was
comparable in both groups (experimental: 22.3% vs control: 22.8%, P = .76).
Baseline IAD severity was 6.9/10 in the experimental group and 7.3/10 in the
control group. A significant intervention effect on IAD prevalence was found
(experimental: 8.1% vs control: 27.1%, F = 3.1, P = .003). A nonsignificant
effect on IAD severity could be determined (experimental: 3.8/10 vs control:
6.9/10, F = 0.8, P = .06).
CONCLUSION: The use of a 3-in-1 washcloth, impregnated with a 3% dimethicone
formula, resulted in a significantly reduced prevalence of IAD and a trend
toward less severe lesions. These findings provide indicative evidence for the
use of 3-in-1 perineal care washcloth as an effective intervention against the
use of water and a pH neutral soap to prevent and/or treat IAD.
DOI: 10.1097/WON.0b013e31822efe52
PMID: 21952346 [Indexed for MEDLINE]
